Gynura segetum

Ethnobotanical Studies

1.

Yi people, Mile, Yunnan, China

Uses: Lumbosacral pain, traumatic injury

DOI:: 10.1186/s13002-024-00656-1
PubMed:: 38395900

Clinical Trials

1.

Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.

Wang X et al (2022).; Hepatol Int.
DOI:: 10.1007/s12072-021-10293-5
PubMed:: 35023026

Studies

1.

A rare case of Gynura-segetum-related hepatic sinus obstruction syndrome complicated with alcoholic liver disease.

Gao Y et al (2024).; J Pak Med Assoc.
DOI:: 10.47391/JPMA.9296
PubMed:: 39028070

2.

Gynura segetum induces hepatic sinusoidal obstruction syndrome in a child: A case report.

Zheng Q and Zhang H (2024).; Medicine (Baltimore).
DOI:: 10.1097/MD.0000000000037341
PubMed:: 38489699

3.

Anticoagulant therapy likely increases risk of bleeding in Gynura segetum-induced hepatic sinus obstruction syndrome.

Tan Y and Zhou X (2024).; Medicine (Baltimore).
DOI:: 10.1097/MD.0000000000035914
PubMed:: 38335400

4.

Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis.

Li S et al (2023).; Cardiovasc Intervent Radiol.
DOI:: 10.1007/s00270-023-03451-9
PubMed:: 37225971

5.

Serum metabolomics strategy for investigating the hepatotoxicity induced by different exposure times and doses of Gynura segetum (Lour.) Merr. in rats based on GC-MS.

Li Y et al (2023).; RSC Adv.
DOI:: 10.1039/d2ra07269f
PubMed:: 36741154

6.

Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum.

Yao J et al (2022).; J Clin Lab Anal.
DOI:: 10.1002/jcla.24793
PubMed:: 36447383

7.

Investigation of Gynura segetum root extract (GSrE) induced hepatotoxicity based on metabolomic signatures and microbial community profiling in rats.

Gu X et al (2022).; Front Microbiol.
DOI:: 10.3389/fmicb.2022.947757
PubMed:: 36016788

8.

Clinical Features and CT Imaging Analysis of Hepatic Sinuscase-Syndrome and Budd-Chiari Syndrome.

Dai F et al (2022).; Int J Gen Med.
DOI:: 10.2147/IJGM.S348176
PubMed:: 35264876

9.

Gynura segetum-induced liver injury leading to acute liver failure: a case report and literature review.

Review

Zhang Z et al (2022).; BMC Complement Med Ther.
DOI:: 10.1186/s12906-022-03549-6
PubMed:: 35260147

10.

Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy.

Zhang H et al (2022).; Acta Cir Bras.
DOI:: 10.1590/ACB361104
PubMed:: 35195181

11.

Herb-induced liver injury: Systematic review and meta-analysis.

Ballotin VR et al (2021).; World J Clin Cases.
DOI:: 10.12998/wjcc.v9.i20.5490
PubMed:: 34307603

12.

Hepatic sinusoidal obstruction syndrome after oral intake of Gynura segetum.

Zhang C et al (2021).; Asian J Surg.
DOI:: 10.1016/j.asjsur.2021.04.015
PubMed:: 33926799

13.

Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.

Zhang L et al (2021).; BMC Gastroenterol.
DOI:: 10.1186/s12876-021-01599-7
PubMed:: 33423668

14.

Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate.

Ou P et al (2019).; Curr Pharm Des.
DOI:: 10.2174/1381612825666191007162024
PubMed:: 31589115

15.

Anti-angiogenic activity of Gynura segetum leaf extracts and its fractions.

Seow LJ et al (2011).; J Ethnopharmacol.
DOI:: 10.1016/j.jep.2010.12.007
PubMed:: 21167271

16.

Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.

Review

Lin G et al (2011).; J Hepatol.
DOI:: 10.1016/j.jhep.2010.07.031
PubMed:: 21146894